LC Interprets for RUSNANO
RUSNANO was founded in March 2011 partly as a venture capital company and through the reorganization of the state corporation Russian Corporation of Nanotechnologies. The primary goal of the company is to develop the Russian nanotechnology industry through co-investment in nanotechnology projects. The Russian Government currently owns 100 % of the company's shares.
Last week (November 29th and 30) Language Connections provided interpreting support during high-level meetings between Anatoly Chubais, the company's CEO, and a few other top RUSNANO executives who met with the Boston and Cambridge entrepreneurial community. Among biotech companies selected were Selecta Biosciences and BIND Biosciences, both companies which are working to develop synthetic vaccines and drugs against various diseases including cancer, malaria, AIDS, influenza, papilloma virus, and nicotine addiction.
Comments